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ABSTRACT
Background: Low maternal iodine intake disturbs the thyroid func-
tion of neonates transiently or permanently.
Objective: To our knowledge, we conducted one of the first sys-
tematic reviews and meta-analyses aimed at exploring the associa-
tion of neonatal thyrotropin concentrations and iodine status of
mothers during pregnancy and early postpartum periods.
Design: Data were collected through literature searches for studies
published between 1969 and 2015 with the use of electronic databases.
Mean or median maternal urinary iodine and neonatal thyrotropin
concentrations, along with other relevant data, were extracted from
eligible studies. The quality and risk of bias of each study was assessed.
Results: A random-effects model was used for the analysis. Of 110
studies identified, 25 trials were shown to be eligible for inclusion in
the meta-analysis. Mean (95% CI) thyrotropin concentrations of
neonates born to mothers with iodine deficiency were higher than
in neonates born to mothers with iodine sufficiency during preg-
nancy in both heel blood samples [1.79 mIU/L (95% CI: 1.61, 1.97
mIU/L) compared with 1.75 mIU/L (95% CI: 1.68, 1.82 mIU/L),
respectively] and cord blood samples [11.91 mIU/L (95% CI: 6.67,
17.14 mIU/L) compared with 6.15 mIU/L (95% CI: 4.30, 8.01
mIU/L), respectively]. There were no significant differences in neo-
natal thyrotropin concentrations of heel samples between mothers
with iodine deficiency and those with sufficiency during the early
postpartum period; however, the values of thyrotropin in cord sam-
ples of neonates born to mothers with iodine deficiency were sig-
nificantly higher than in neonates born to mothers with iodine
sufficiency [11.62 mIU/L (95% CI: 10.47, 12.77 mIU/L) compared
with 7.40 mIU/L (95% CI: 6.21, 8.59 mIU/L)].
Conclusion: Our findings reveal that, compared with heel blood
samples, neonatal thyrotropin in samples collected from the cord
are more sensitive to the iodine status of mothers; however, further
investigations are required in this regard. Am J Clin Nutr
2016;104:1628–38.
Keywords: iodine deficiency disorder, iodine nutrition, maternal
urinary iodine, neonatal thyrotropin, pregnancy, postpartum, heel
blood sample, cord blood sample
INTRODUCTION
On the basis of UNICEF estimations, currently .35 million
newborns annually suffer from brain damage that is associated
with iodine deficiency (1–3). In situations of iodine deficiency,
even in its mild form, the production of thyroid hormones has
been compromised, which causes increased thyroid-stimulating
hormone (TSH) secretion. Therefore, an elevated TSH, also
known as thyrotropin, is a sensitive indicator for iodine-nutrition
insufficiency and, hence, an inadequate supply of thyroid hor-
mones to the developing brain. However, neonatal thyrotropin
concentrations have been shown to vary because of the influence
of several prenatal and postnatal factors such as, e.g., the timing
of blood sampling, type of TSH assay used, and season of birth.
The WHO has proposed a frequency of neonatal TSH concen-
trations .5 mIU/L as ,3% for the threshold for iodine suffi-
ciency. Frequencies of 3–19.9%, 20–39.9%, and .40% may be
observed in conditions of mild, moderate, and severe iodine
deficiency, respectively (4–6).
It is well known that low maternal iodine intake disturbs the
thyroid function of neonates transiently or permanently, although
there have been controversial results regarding the association
between neonatal TSH and maternal urinary iodine concentra-
tions (UICs) (7). Data from newborn screenings in Turkey (8),
Thailand (9), and Hong Kong (10) have shown that TSH was
higher in neonates of mothers who had lower UICs. However,
studies from Australia (11) and Denmark (12), which are
countries with mild to borderline iodine deficiency, did not show
the previously documented negative correlation between neo-
natal TSH and maternal UIC.
In contrast, there are limited data on the effects of maternal
dietary iodine intake on neonatal thyroid function in a population
chronically exposed to excess dietary iodine intake. A transient
elevation of TSH was observed in some neonates born to Jap-
anese mothers who consumed iodine-rich foods during preg-
nancy or in lactation such as seaweed and kelp; however, there
was no direct relation between maternal UIC and neonatal TSH
(13). In China, the TSH of neonates born to mothers living with
long-term excessive iodine intake from drinking water was higher
than in neonates born to mothers residing in areas with adequate
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iodine intake (14). Moreover, both iodine fortification and sup-
plementation for mothers residing in areas with iodine deficiency
are usually associated with a decrease in neonatal TSH con-
centrations (15–17); however, studies have shown inconclusive
results. For instance, in Australia and Denmark, neonates born to
mothers who took iodine-containing supplements had a shift in
distribution toward higher TSH concentrations (12, 18).
These findings raise the question of whether the neonatal TSH
concentration truly reflects the iodine status of mothers who have
higher iodine requirements. Hence, this systematic review and
meta-analysis explores, for the first time to our knowledge, the
association of the neonatal thyrotropin concentration and iodine
status of mothers during pregnancy and early postpartum periods.
METHODS
Search strategy
We conducted a systematic literature search of all articles that
were published between September 1969 and March 2015 with the
use of electronic databases [i.e., MEDLINE/PubMed (National
Library of Medicine; www.pubmed.com), Institute of Scientific
InformationWeb of Science (www.webofscience.com), the Cochrane
Library CENTRAL (www.cochrane.org), and Scopus (www.scopus.
com)]. Additional searches were conducted with the use of relevant
databases [i.e., the WHO (http://www.who.int/en/), International
Council for the Control of Iodine Deficiency Disorders (http://www.
iccidd.org/), and UNICEF (http://www.unicef.org/)]. Moreover, In-
ternet searches were also carried out with general search engines
(Google and Google Scholar). The key terms included in the search
were as follows: iodine nutrition, lactating mothers, postpartum
women, pregnant women, iodine and lactation, iodine and
breastfeeding, iodine and pregnancy, urinary iodine, neonatal
TSH screening, neonatal thyrotropin, congenital hypothyroidism
screening program, neonatal thyroid function, and neonatal TSH.
To further identify relevant papers, we also performed a manual
search with the use of reference lists of original articles and
relevant reviews.
Study selection and data extraction
Two of the investigators conducted the search independently.
Once the search was completed, the titles and abstracts of the
studies identified were scanned to exclude studies that were
obviously irrelevant. Full texts of the remaining studies were
retrieved, and all relevant articles were identified. Criteria for
inclusion of studies in the systematic review were as follows: all
articles were human studies that included healthy pregnant
women and postpartum mothers (during the first few weeks after
delivery at the time of congenital hypothyroidism screening), and
their healthy full-term neonates as target participants were also
assessed; maternal UICs and neonatal thyrotropin concentrations
were reported, and the type of blood sampling for neonatal
thyrotropin was determined. Exclusion criteria were as follows:
animal studies; non-English studies; studies in which mothers or
infants had been exposed to environmental factors [i.e., per-
chlorate, tobacco smoking, and iodine overload (e.g., iodine
containing contrast media, radioactive iodine, and povidone-
iodine disinfection)] that can influence their iodine status and
thyroid function; studies conducted in pregnant and postpartum
women with thyroid diseases or in preterm and unhealthy infants;
and any duplicate publications or any potentially relevant articles
that lacked full texts.
Data from included studies were extracted by 2 investigators
independently on standardized forms that were developed for this
review, and if any discrepancies were shown, the studies were
removed by consensus. The following data were extracted: first
author; year of publication; country or location of study; number
of mothers and infants; mean or median maternal UICs and
neonatal thyrotropin concentrations or the percentage of neonate
with TSH concentrations .5 mIU/L; type of sampling for the
thyrotropin concentration (cord compared with heel); and cor-
relation coefficients between maternal UICs and neonatal thy-
rotropin concentrations.
Quality assessment
We assessed study quality with the use of the Newcastle-
Ottawa Scale and scored each study on the basis of 3 different
points of view (i.e., the selection of the study samples, compa-
rability of the groups, and ascertainment of the outcome of in-
terest). Each study received 0, 1, and 2 stars for each criterion,
and an overall quality score was calculated as the sum of in-
dividual stars. For descriptive purposes, we used the Newcastle-
Ottawa scores 2–3, 4–6, and 7–10 as having low, moderate, and
high quality, respectively.
Data synthesis
All medians, lower and upper CIs, minimums and maximums,
IQRs, and sample sizes in each study were changed to means 6
SDs or SEs for further calculations. According to the WHO/
International Council for the Control of Iodine Deficiency Dis-
orders/UNICEF criteria, median UICs ,150 and$150 mg/L for
pregnant women, and median UICs ,100 and $100 mg/L for
postpartum mothers were considered as iodine deficiency and
sufficiency, respectively. In studies that were conducted in dif-
ferent regions of a country, with different iodine statuses, we
included each region as a separate study. If studies reported
neonatal thyrotropin in different surveys from a country, we
included each survey as a separate study. If neonatal thyrotropin
concentrations were reported in different types of blood sam-
pling (heel or cord), they were included in our study as 2 sep-
arate studies. In studies in which the maternal UIC was assessed
during pregnancy and early postpartum periods, we included
each period (time point) as a separate study.
Statistical analysis
Means and 95% CIs of TSH were estimated in different
subgroups on the basis of the mother’s status (pregnant or
breastfeeding) and type of blood sampling. The random-effects
model was used because of the presence of heterogeneity, which
was assessed with the use of Cochrane’s Q statistics and I2 (19).
The presence of publication bias was also evaluated with the use
of both Begg and Egger tests as well as funnel plots (20). A
forest plot was used for showing means and 95% CIs of TSH in
different subgroups. Stata 12.0 software (Stata Corp LP) was
used for all analyses.
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RESULTS
Study characteristics
The flowchart for this review is shown in Figure 1. We
screened a total of 110 titles and abstracts after the electronic
search. Of these articles, 59 studies appeared to be potentially
relevant and were assessed as full-text articles for inclusion.
Thirty-one potential studies were excluded because of a lack of
inclusion criteria. The main reason for the exclusion of an article
was that it did not report any data for the UIC in pregnant and
postpartum women or neonatal thyrotropin concentrations.
Further, one additional publication was included from the
screening of reference lists, which yielding a total of 29 articles
for inclusion in the current systematic review. Of these articles,
16 studies assessed UICs in pregnant women (Table 1), 10
studies reported the iodine nutrition status in mothers during the
early postpartum periods (Table 2), and 3 studies measured
maternal urinary iodine during both pregnancy and early post-
partum periods. Sixteen studies reported on neonatal thyrotropin
with the use of dried heel-prick blood spots, 11 studies assessed
neonatal thyrotropin in cord blood samples, 1 study reported
the use of 2 types of blood sampling, and only 1 study assessed
the TSH of newborns with the use of a venous blood sample.
Mean or median neonatal TSH was expressed in all studies,
except in 3 studies in which the frequency of neonates with
TSH concentrations .5 mIU/L was reported. After the ex-
clusion of studies that reported neonatal TSH as a percentage
(n = 3) and as a venous blood sample (n = 1), 25 studies were
shown to be eligible for inclusion in the meta-analysis.
Quality scores of studies included in the meta-analysis ranged
from 6 to 8 (Table 3). The majority of studies received high-
quality scores, and 8 studies were scored as being of moderate
quality.
Neonatal TSH concentrations of heel samples of infants
born to mothers with sufficient compared with deficient
iodine nutrition
The forest plot with means and 95% CIs and the pooled es-
timates for means of neonatal TSH of heel blood samples of
infants born to mothers with deficient and sufficient urinary
iodine during pregnancy are illustrated in Figure 2. The plot
FIGURE 1 Flowchart for the selection of studies for the systematic review and meta-analysis. TSH, thyroid-stimulating hormone.
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revealed substantial heterogeneity between study-specific
estimates (test for heterogeneity: I2= 93.4% and 99.8%, respectively;
P, 0.001 for both), and hence, the random-effects model was
considered to provide a more-appropriate estimate. There was
no publication bias in these subgroups. Mean thyrotropin con-
centrations of neonates born to mothers with iodine defi-
ciency were higher than in neonates born to mothers with iodine
sufficiency during pregnancy; however, when 95% CIs were
compared, no significant difference was observed between
the 2 iodine statuses [1.79 mIU/L (95% CI: 1.61, 1.97 mIU/L)
compared with 1.75 mIU/L (95% CI: 1.68, 1.82 mIU/L)]. In
Figure 3, the forest plot shows studies with means and 95% CIs
and the pooled estimates for means of TSH concentrations of
neonates born to mothers with different iodine statuses during
the early postpartum period. Study-specific estimates exhibited
substantial heterogeneity between studies (I2 = 97.5% and
TABLE 1
Neonatal thyrotropin concentrations and maternal urinary iodine concentrations during pregnancy1
Study authors, year (ref) Country Neonates, n
Neonatal TSH,
mIU/L
Type of
sampling Mothers, n Maternal UIC, mg/L Correlation
Travers et al., 2006 (22) Australia 824 1.1 (1.60)2 Heel blood 815 85.0 (58.0)2 No
McElduff et al., 2002 (11) Australia 84 1.8 (1.1–2.7)2 Heel blood 84 109.0 (65.0–168.0)2 Yes
Chen et al., 2015 (14) China 2103 7.3 (5.5, 11.1)4 Cord blood 210 1241.0 (672.0, 1965.0)4 Yes
1743 4.7 (3.9, 6.0)4 Cord blood 174 217.0 (146.0, 333.0)4
Luton et al., 2011 (23) France 72 7.7 6 0.85 Cord blood 1026 48.0 6 2.0 NS
636 52.4 6 4.0
Copeland et al., 2002 (24) Guatemala 141 587 Cord blood 141 120.0 (99.0, 149.0)8 NS
Kung et al., 1997 (10) Hong Kong 269 18.4 (2.0, 45.0)4 Cord blood 253 124.0 (12.6, 260.7)4 NS
1429 6.6 (1.7, 30.0)4 Cord blood
Charoo et al., 2013 (25) India 51 3.8 6 1.4 Venous blood 516 144.0 6 17.6 NS
133.5 6 15.4
123.3 6 14.8
Chakraborty et al., 2006 (26) India 267 4.1 Cord blood 267 144.0 NS
Azizi et al., 2011 (27) Iran 529 7.3 (5.3–11.3)2 Cord blood 526 125.0 (55.0–143.0)2 No
212.0 (150.0–488.0)2
97.0 (20.0–147.0)2
869 7.5 (5.5–10.3)2 Cord blood 866 213.0 (155.0–400.0)2
93.0 (22.0–147.0)2
227.0 (155.0–400.0)2
Burns et al., 2008 (21) Ireland 640610 1.8 6 2.6 Heel blood 36 52.0 6 5.8 Yes
542110 1.6 6 1.9 Heel blood 18 81.0 6 12.2
Fuse et al., 2011 (13) Japan 711 2.5 (1.7–3.8)2 Heel blood 683 219.0 (124.0–436.0)2 No
Ojule and Osotimehin, 1998 (28) Nigeria 1053 9.8 6 1.6 Cord blood 105 144.7 6 14.7 NS
903 4.2 6 1.2 Cord blood 90 213.4 6 10.0
Costeira et al., 2009 (29) Portugal 117 1.6 6 1.2 Heel blood 1366 65.0 (28.0–100.0)2 No
1286 57.0 (33.0–95.0)2
1196 70.0 (40.0–100.0)2
Velasco et al., 2013 (30) Spain 16111 12.2 6 9.1 Cord blood 233 126.5 (133.9, 160.4)8 Yes
22711 1.5 6 1.3 Heel blood NS
Aguayo et al., 2013 (31) Spain 1868 2.97 Heel blood 21046 88.5 (16.0, 875.0)4 No
13226 140.0 (21.0, 880.0)4
Marco et al., 2010 (32) Spain 525 1.0 (0.7–1.6)2 Heel blood 525 164.0 (116.0–245.0)2 No
Zimmermann et al., 2005 (17) Switzerland 259,03510 1.2 (0.8–1.9)2 Heel blood 511 138.0 (5.0, 1881.0)4 NS
218,66510 1.2 (0.8–1.8)2 Heel blood 279 249.0 (8.0, 995.0)4
Sukkhojaiwaratkul et al., 2014 (16) Thailand 518110 5.2 (0.01, 35.1)4 Cord blood 218 196.5 (11.5, 1174.0)4 NS
833210 7.3 (0.01, 87.7)4 Cord blood 270 161.0 (14.5, 1046.0)4
Jaruratanasirikul et al., 2009 (9) Thailand 236 2.4 6 1.6 Heel blood 2366 75.5 (50.0, 105.0)4 No
87.6 (50.0, 105.0)4
72.1 (50.0, 105.0)4
Copeland et al., 2002 (24) USA 243 827 Cord blood 243 105.0 (90.0, 117.0)8 NS
1NS, not stated; ref, reference; TSH, thyroid-stimulating hormone; UIC, urinary iodine concentration.
2Median; IQR in parentheses.
3 Results from different regions of a country with different iodine statuses.
4Median; minimum, maximum in parentheses.
5Mean 6 SD (all such values).
6 Results from different stages of pregnancy.
7 Percentage of TSH concentrations .5 mIU/L.
8Median; 95% CI in parentheses.
9 Results from neonates born to mothers with different iodine statuses.
10 Results from different surveys of a country.
11 Results from different types of blood sampling.
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99.2%, respectively; P , 0.001 for both); no publication bias
was shown in these subgroups. Mean thyrotropin concentrations
of neonates born to mothers with iodine deficiency and of ne-
onates born to mothers with iodine sufficiency during the early
postpartum period were 3.37 mIU/L (95% CI: 2.71, 4.02 mIU/L)
and 3.85 mIU/L (95% CI: 2.76, 4.94 mIU/L), respectively. A
comparison of 95% CIs showed that none of these values were
significant. Taken together, in iodine-deficient mothers who
were either pregnant or postpartum, mean newborn TSH con-
centrations of heel samples ranged between 1.79 mIU/L (95%
CI: 1.61, 1.97 mIU/L) and 3.37 mIU/L (95% CI: 2.71, 4.02 mIU/L),
whereas these values in iodine-sufficient mothers ranged between
1.75 mIU/L (95% CI: 1.68, 1.82 mIU/L) and 3.85 mIU/L (95% CI:
2.76, 4.94 mIU/L).
Neonatal TSH concentrations of cord samples of offspring
born to mothers with sufficient compared with deficient
iodine nutrition
Figure 4 shows a forest plot of studies with means and 95%
CIs and pooled estimates for mean neonatal TSH concentrations
of cord samples of offspring born to mothers with deficient uri-
nary iodine and of offspring born to mothers with sufficient uri-
nary iodine. There was significant heterogeneity between studies
that were conducted in pregnant women (I2 = 100% and 99.8%,
respectively; P , 0.001 for both). We showed no publication bias
in these subgroups. The mean thyrotropin value of newborns born
to mothers with iodine deficiency was higher than in newborns
born to mothers with iodine sufficiency during pregnancy; how-
ever, a comparison of 95% CIs showed no significant differ-
ence between the iodine status of these 2 groups of mothers
[11.91 mIU/L (95% CI: 6.67, 17.14 mIU/L) compared with 6.15
mIU/L (95% CI: 4.30, 8.01 mIU/L), respectively]. As shown in
Figure 5, mean neonatal thyrotropin concentrations of offspring
born to mothers with iodine deficiency was significantly higher
than in offspring born to mothers with iodine sufficiency during
the early postpartum period [11.62 mIU/L (95% CI: 10.47, 12.77
mIU/L) compared with 7.40 mIU/L (95% CI: 6.21, 8.59 mIU/L),
respectively]; however, because of the small sample size of the
study in each group of iodine status, the results may have been in-
conclusive. Generally, in iodine-deficient mothers who were either
pregnant or postpartum, newborn TSH concentrations of cord sam-
ples ranged between 11.62 mIU/L (95% CI: 10.47, 12.77 mIU/L)
and 11.91 mIU/L (95% CI: 6.67, 17.14 mIU/L), whereas, new-
born TSH concentrations of cord samples in iodine-sufficient
mothers ranged between 6.15 mIU/L (95% CI: 4.30, 8.01 mIU/L)
and 7.40 mIU/L (95% CI: 6.21, 8.59 mIU/L).
Neonatal TSH concentrations of heel samples compared
with cord samples of newborns born to mothers with
sufficient and deficient iodine nutrition
A summary of pooled estimates of TSH concentrations of
neonates born to mothers with different iodine statuses by type of
TABLE 2
Neonatal thyrotropin concentrations and maternal urinary iodine values during early postpartum1
Study authors, year (ref) Country Neonates, n
Neonatal
TSH, mIU/L
Type of
sampling Mothers, n Maternal UIC, mg/L Correlation
Chan et al., 2003 (18) Australia 50 1.5 (0.2, 21.0)2 Heel blood 50 46.0 (4.0, 140.0)2 No
Copeland et al., 2002 (24) Bangladesh 208 843 Cord blood 208 96.0 (81.0, 111.0)4 NS
Tahirovic et al., 2009 (33) Bosnia and
Herzegovina
47 3.0 (0.7, 12.0)2 Heel blood 47 134.0 (12.0, 3360.0)2 NS
Hashemipour et al., 2010 (34) Iran 179 5.4 (4.0, 22.0)2 Heel blood 179 130.0 (20.0, 400.0)2 No
Ordookhani et al., 2007 (35) Iran 48 7.1 (1.5, 18.2)2 Cord blood 48 107.0 (20.0, 710.0)2 No
Fuse et al., 2011 (13) Japan 711 2.5 (1.7–3.8)5 Heel blood 533 135.0 (78.0–262.0) No
Sullivan et al., 1997 (36) Malaysia 195 523 Cord blood 194 33.0 NS
Fuse et al., 2003 (37) Mongolia 138 3.1 6 2.46 Heel blood 138 107.0 (9.0, 840.0)2 No
Costeira et al., 2009 (29) Portugal 117 1.6 6 1.26 Heel blood 887 35.0 (15.0–98.0) No
1057 50.0 (28.0–84.0)
737 40.0 (20.0–83.0)
Rajatanavin, 2007 (38) Thailand 10238 5.8 (2.2, 2.5)4 Heel blood 1023 85.0 No
1818 5.7 (2.2, 2.5)4 181 249.0
2038 6.5 (2.2, 2.5)4 203 106.0
Yaman et al., 2013 (39) Turkey 116 7.2 6 5.76 Heel blood 116 84.0 NS
Kurtoglu et al., 2004 (40) Turkey 70 7.4 (1.1, 30.5)2 Cord blood 70 30.2 (3.2, 171.5)2 NS
Simsek et al., 2005 (8) Turkey 52109 5.5 6 0.210 Heel blood 57 48.8 6 8.710 NS
61409 4.9 6 0.210 68 55.4 6 6.110
72569 3.9 6 0.0510 65 71.6 6 9.810
1 NS, not stated; ref, reference; TSH, thyroid-stimulating hormone; UIC, urinary iodine concentration.
2Median; minimum, maximum in parentheses.
3 Percentage of TSH . 5mIU/L.
4Median; 95% CI in parentheses.
5Median; IQR in parentheses (all such values).
6Mean 6 SD.
7 Results from different times of postpartum.
8 Results from different surveys of a country.
9 Results from different regions of a country.
10Mean 6 SEM.
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blood sampling is given in Table 4. In the analysis that was
stratified by the type of blood sampling, the pooled (95% CI)
neonatal TSH concentrations of heel and cord samples of new-
borns born to mothers with iodine sufficiency during pregnancy
were 1.75 mIU/L (95% CI: 1.68, 1.82 mIU/L) and 6.15 mIU/L
(95% CI: 4.30, 8.01 mIU/L), respectively; however, in neonates
born to mothers with iodine sufficiency during the early post-
partum period, these values were 3.85 mIU/L (95% CI: 2.76,
4.94 mIU/L) and 7.40 mIU/L (95% CI: 6.21, 8.59 mIU/L), re-
spectively. The weighted (95% CI) neonatal TSH concentrations
of heel and cord samples of offspring born to mothers with iodine
deficiency during pregnancy were 1.79 mIU/L (95% CI: 1.61,
FIGURE 2 Means (95% CIs) and pooled estimates for means of neonatal TSH of heel blood samples of infants born to mothers with different iodine
statuses during pregnancy. The subgroup analysis was based on maternal iodine status during pregnancy. Open diamonds represent pooled estimates for each
subgroup and the overall estimate for the neonatal TSH of heel blood samples. Solid diamonds represent point estimates of studies (horizontal lines represent
95% CIs), and sizes of squares are proportional to the percentages of weight of studies. I2 values refer to the statistical heterogeneity within each subgroup and
combined studies. A random-effects model was used to calculate weighted mean differences and 95% CIs. Ref, reference; TSH, thyroid-stimulating hormone.
FIGURE 3 Means (95% CIs) and pooled estimates for means of neonatal TSH of heel blood samples of infants born to mothers with different iodine statuses
during the early period of postpartum. A subgroup analysis was based on maternal iodine status during the early period of postpartum. Open diamonds represent pooled
estimates for each subgroup and the overall estimate for the neonatal TSH of heel blood samples. Solid diamonds represent point estimates of studies (horizontal lines
represent 95% CIs), and sizes of squares are proportional to the percentages of weight of studies. I2 values refer to the statistical heterogeneity within each subgroup and
combined studies. A random-effects model was used to calculate weighted mean differences and 95% CIs. Ref, reference; TSH, thyroid-stimulating hormone.
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1.97 mIU/L) and 11.91 mIU/L (95% CI: 6.67, 17.14 mIU/L),
respectively. However, these values in neonates born to
mothers with iodine deficiency during the early postpartum
period were 3.37 mIU/L (95% CI: 2.71, 4.02 mIU/L) and
11.62 mIU/L (95% CI: 10.47, 12.77 mIU/L), respectively. In
both pregnant and postpartum women, significant differences
were shown between thyrotropin concentrations of heel and
cord samples.
DISCUSSION
To the best of our knowledge, this is the first systematic review
and meta-analysis to be conducted on the maternal iodine nu-
trition status and neonatal thyrotropin concentration. In the
current study, meta-analyses of available studies indicated that
thyrotropin concentrations of heel and cord samples in neonates
born to mothers with iodine deficiency were higher than in ne-
onates born to mothers with iodine sufficiency during pregnancy;
FIGURE 4 Means (95% CIs) and pooled estimates for means of neonatal TSH of cord blood samples of offspring born to mothers with different iodine
statuses during pregnancy. The subgroup analysis was based on maternal iodine status during pregnancy. Open diamonds represent pooled estimates for each
subgroup and the overall estimate for the neonatal TSH of cord blood samples. Solid diamonds represent point estimates of studies (horizontal lines represent
95% CIs), and sizes of squares are proportional to the percentages of weight of studies. I2 values refer to the statistical heterogeneity within each subgroup and
combined studies. A random-effects model was used to calculate weighted mean differences and 95% CIs. Ref, reference; TSH, thyroid-stimulating hormone.
FIGURE 5 Means (95% CIs) and pooled estimates for means of neonatal TSH of cord blood samples of offspring born to mothers with different iodine
statuses during the early period of postpartum. The subgroup analysis was based on maternal iodine status during the early period of postpartum. Open
diamonds represent pooled estimates for each subgroup and the overall estimate for the neonatal TSH of cord blood samples. Solid diamonds represent point
estimates of studies (horizontal lines represent 95% CIs), and sizes of squares are proportional to the percentages of weight of studies. I2 values refer to the
statistical heterogeneity within combined studies. Assessment of heterogeneity within different subgroups was not possible because of only one study being
included in each group of iodine status. A random-effects model was used to calculate weighted mean differences and 95% CIs. Ref, reference; TSH, thyroid-
stimulating hormone.
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however, no significant difference was observed between the
2 iodine statuses. Although only 2 studies were conducted in
postpartummothers that reported the neonatal thyrotropin in cord
blood samples, the values of cord samples in newborns born to
mothers with iodine deficiency were significantly higher than in
newborns born to mothers with iodine sufficiency.
Effects of maternal inadequate iodine intakes compared
with excessive iodine intakes on neonatal thyrotropin
concentrations
The neonatal thyroid gland has a lower iodine content and
higher iodine turnover than in thyroid glands of adults; hence, in
infants born to mothers with an inadequate iodine status, the
decrease of thyroid hormone production is much faster in the
neonate than in the mother (7, 21). However, there is not enough
evidence to confirm the higher sensitivity of thyroid function to
iodine deficiency in full-term infants compared with in their
mothers (42). In contrast, excessive iodine intake has an inhibitory
effect on the thyroid gland, indicating that the fetal thyroid is more
susceptible to this inhibitory effect than are adult glands, thereby
resulting in hyperthyrotropinemia in newborns; e.g., in Japan and
China, a transient elevation of TSH was reported in some neonates
born to mothers who were chronically exposed to high doses of
iodine mainly from foods and drinking water (13, 14).
Effects of iodized salt fortification compared with maternal
iodine supplementation on neonatal thyrotropin
concentrations
A nationwide survey in Switzerland showed that a 25% in-
crease in the content of iodized salt (from 15 to 20 parts per
million) markedly improved the iodine status in pregnant women
with an improvement that was reflected in the frequency of
neonate TSH concentrations .5 mIU/L from 2.9% to 1.7%
between the years 1992–1998 and 1999–2004 (17). A similar
pattern was observed in the Islamic Republic of Iran, which was
previously known as an area of iodine deficiency (43), where the
production and nationwide consumption of iodized salt con-
taining 20–40 parts per million iodine began in 1990 and was
legislated for household consumption by 1994 (44, 45). The
assessment of transient neonatal hypothyroidism in Tehran and
Damavand (2 cities in the Tehran province) in 1998 and 2000
indicated that hyperthyrotropinemia significantly decreased from
5% to 1.6% after salt-iodization programs (15, 46).
Different studies have shown that, in populations with mild to
moderate iodine deficiency, children of mothers who took iodine-
containing supplements had higher cord blood TSH values,
which was an observation that was not consistent with previously
documented direct associations between iodine deficiency and
neonatal thyrotropin TSH values (12, 47, 48). In Denmark, cord
TSH concentrations.10 mIU/L were observed in 41% of newborns
whose mothers were supplemented with 150 mg iodine/d dur-
ing pregnancy, whereas TSH concentrations .10 mIU/L were
present in only 31% of control neonates (12). Consistently, in
Thailand after iodine supplementation during pregnancy, the
percentage of neonates who had cord blood TSH concentra-
tions .10 mIU/L was 11.7%, whereas the maternal median
UIC was 170.6 mg/L (16). However, a clinical trial that was
conducted in Belgium on iodine supplementation in pregnant
women showed no differences in TSH concentrations of neo-
nates born to women who had received iodine supplements and
in neonates born to women who had did not received iodine
supplements (49).
Thyrotropin as a reliable indicator for monitoring iodine
status during pregnancy and early postpartum periods
The application of neonatal TSH values in the determination of
iodine status at population levels has been successful in some
countries (8–10); however, some regions have reported con-
flicting or uncertain data (11, 12, 50). It is assumed that the
thyroid of newborns is very sensitive to iodine status, and even
mild iodine deficiency during pregnancy will cause an increase
in neonatal TSH secretion. Our results revealed that thyrotropin
concentrations of neonates born to mothers with iodine de-
ficiency were higher (but not significantly) than in neonates born
to mothers with iodine sufficiency during pregnancy in both heel
blood samples (mean: 1.79 compared with 1.75 mIU/L, re-
spectively) and cord blood samples (mean: 11.91 compared with
6.15 mIU/L, respectively). Although there were small sample
sizes of studies with cord blood samples in mothers during the
early postpartum period, neonates born to mothers with iodine
deficiency had significantly higher thyrotropin concentrations
than did neonates who were born to mothers with iodine suffi-
ciency (11.62 compared with 7.40 mIU/L, respectively). In
Switzerland, a significant decrease in the frequency of neonatal
TSH concentrations .5 mIU/L was associated with an increase
in the median UIC in pregnant women (from 138.0 to 249.1 mg/L)
(17). In a study conducted in Australian lactating mothers,
a median UIC ,50 mg/L was consistent with the percentage of
neonatal TSH concentrations .5 mIU/L of . 3% (18). Our
findings confirmed that, in conditions of iodine deficiency,
neonatal thyrotropin concentrations tend to be elevated, al-
though higher values of TSH do not necessarily reflect an in-
crease in the proportion of TSH concentrations .5 mIU/L. For
instance, the national neonatal screening programs in Ireland
have shown that the shift to the right in the distribution of TSH
values was not accompanied by the presence of a large number
of concentrations .5 mIU/L (21).
However, the discrepancy between neonatal TSH and maternal
UIC has been reported in the literature, which has suggested that
the percentage of TSH concentrations .5 mIU/L may not be
sensitive enough to evaluate iodine status, especially when io-
dine deficiency is mild (51). A study from Australia showed that
TABLE 4
Summary of pooled estimates of neonatal thyrotropin born to mothers with
different iodine statuses by type of blood sampling1
Neonatal thyrotropin concentration, mIU/L
Heel sample Cord sample
Pregnant women
Iodine sufficient 1.75 (1.68, 1.82) 6.15 (4.30, 8.01)
Iodine deficient 1.79 (1.61, 1.97) 11.91 (6.67, 17.14)
Postpartum mothers
Iodine sufficient 3.85 (2.76, 4.94) 7.40 (6.21, 8.59)
Iodine deficient 3.37 (2.71, 4.02) 11.62 (10.47, 12.77)
1All values are pooled means; 95% CI in parentheses.
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only 2.2% of neonates had TSH concentrations .5 mIU/L de-
spite a median UIC of 85.0 mg/L in pregnant women (52).
Similarly, the percentage of TSH concentrations .5 mIU/L in
infants born to mildly iodine-deficient mothers in Belgium be-
tween 2009 and 2011 was unexpectedly low and fluctuated be-
tween 2.6% and 3.3% (50). Even in France, which is considered
an area of moderate iodine deficiency, low maternal UIC was not
accompanied by high concentrations of cord blood TSH (53).
The main strength of this research is that, to our knowledge, it
is the first systematic review and meta-analysis to investigate the
effect of maternal iodine status on neonatal thyrotropin con-
centrations in both cord and heel blood samples. However, the
small sample sizes of studies in certain subgroups of maternal
iodine status may not have provided reliable estimations of
neonatal thyrotropin. In the current study, we excluded studies
that reported the use of a povidone iodine application; however,
the exposure of mothers or infants to povidone iodine has not
been mentioned in some studies. Another potential limitation was
related to several influential factors, such as, e.g., the mode of
delivery, the TSH assay methodology, gestational age, season of
birth, sex of the newborn, and birth weight, that could have
possibly been the source of heterogeneity that was observed
across the studies included; however, we could not determine the
source of heterogeneity with the use of a meta-regression analysis
because of the small sample sizes of studies within different
subgroups; last, because of the limited number of studies, we
were also not able to include the previously mentioned influential
issues in the analysis, which makes the interpretation of our
results difficult.
In conclusion, although neonatal thyrotropin constitutes an
index of monitoring the iodine status in populations and in-
tervention programs, it can be influenced by several prenatal and
postnatal factors of which maternal iodine status plays the crucial
role. The findings of our meta-analysis reveal that, compared with
iodine sufficiency, iodine deficiency during pregnancy results in
higher values of neonatal thyrotropin in both heel and cord blood
samples. Also, in conditions of iodine deficiency during early
postpartum, a significant increase in TSH values of cord blood
samples can be observed; however, caution is needed in inter-
preting this data because of the limited number of studies on cord
blood samples in neonates born to mothers with different iodine
statuses during the early postpartum period. It seems that, despite
this limitation, neonatal thyrotropin in samples collected from
cord blood is more sensitive to the iodine status of mothers. To
confirm these findings, the sensitivity of neonatal TSH at different
degrees of iodine deficiency needs to be assessed in subsequent
studies. Furthermore, future meta-analyses on neonatal thyro-
tropin in different subgroups of influential factors are warranted.
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